S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.41 (+0.28%)
MSFT   319.07 (-0.14%)
META   304.27 (+2.89%)
GOOGL   130.65 (+0.16%)
AMZN   131.45 (+1.64%)
TSLA   254.15 (-0.61%)
NVDA   418.35 (+1.99%)
NIO   8.58 (+1.54%)
BABA   87.90 (+4.51%)
AMD   96.84 (+0.76%)
T   15.10 (-1.37%)
F   12.51 (+2.54%)
MU   68.62 (+1.06%)
CGC   0.78 (+1.68%)
GE   112.66 (-0.29%)
DIS   82.58 (-0.18%)
AMC   7.75 (+0.65%)
PFE   32.54 (-0.94%)
PYPL   58.53 (-0.15%)
NFLX   382.51 (-0.43%)
S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.41 (+0.28%)
MSFT   319.07 (-0.14%)
META   304.27 (+2.89%)
GOOGL   130.65 (+0.16%)
AMZN   131.45 (+1.64%)
TSLA   254.15 (-0.61%)
NVDA   418.35 (+1.99%)
NIO   8.58 (+1.54%)
BABA   87.90 (+4.51%)
AMD   96.84 (+0.76%)
T   15.10 (-1.37%)
F   12.51 (+2.54%)
MU   68.62 (+1.06%)
CGC   0.78 (+1.68%)
GE   112.66 (-0.29%)
DIS   82.58 (-0.18%)
AMC   7.75 (+0.65%)
PFE   32.54 (-0.94%)
PYPL   58.53 (-0.15%)
NFLX   382.51 (-0.43%)
S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.41 (+0.28%)
MSFT   319.07 (-0.14%)
META   304.27 (+2.89%)
GOOGL   130.65 (+0.16%)
AMZN   131.45 (+1.64%)
TSLA   254.15 (-0.61%)
NVDA   418.35 (+1.99%)
NIO   8.58 (+1.54%)
BABA   87.90 (+4.51%)
AMD   96.84 (+0.76%)
T   15.10 (-1.37%)
F   12.51 (+2.54%)
MU   68.62 (+1.06%)
CGC   0.78 (+1.68%)
GE   112.66 (-0.29%)
DIS   82.58 (-0.18%)
AMC   7.75 (+0.65%)
PFE   32.54 (-0.94%)
PYPL   58.53 (-0.15%)
NFLX   382.51 (-0.43%)
S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.41 (+0.28%)
MSFT   319.07 (-0.14%)
META   304.27 (+2.89%)
GOOGL   130.65 (+0.16%)
AMZN   131.45 (+1.64%)
TSLA   254.15 (-0.61%)
NVDA   418.35 (+1.99%)
NIO   8.58 (+1.54%)
BABA   87.90 (+4.51%)
AMD   96.84 (+0.76%)
T   15.10 (-1.37%)
F   12.51 (+2.54%)
MU   68.62 (+1.06%)
CGC   0.78 (+1.68%)
GE   112.66 (-0.29%)
DIS   82.58 (-0.18%)
AMC   7.75 (+0.65%)
PFE   32.54 (-0.94%)
PYPL   58.53 (-0.15%)
NFLX   382.51 (-0.43%)
NASDAQ:HOLX

Hologic (HOLX) Stock Forecast, Price & News

$70.26
+0.19 (+0.27%)
(As of 09:51 AM ET)
Compare
Today's Range
$70.13
$70.60
50-Day Range
$70.07
$81.90
52-Week Range
$59.78
$87.88
Volume
52,631 shs
Average Volume
1.59 million shs
Market Capitalization
$17.21 billion
P/E Ratio
36.40
Dividend Yield
N/A
Price Target
$88.92

Hologic MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
26.2% Upside
$88.92 Price Target
Short Interest
Healthy
1.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.41
Upright™ Environmental Score
News Sentiment
1.01mentions of Hologic in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
1.79%
From $3.92 to $3.99 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.84 out of 5 stars

Medical Sector

57th out of 965 stocks

X-Ray Apparatus & Tubes Industry

1st out of 5 stocks


HOLX stock logo

About Hologic (NASDAQ:HOLX) Stock

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Price History

HOLX Stock News Headlines

Hologic Inc. stock falls Thursday, underperforms market
30 Days of MarketBeat All Access Free
Access our premier stock research platform that includes research tools, stock screeners, instant alerts, real-time news and much more.
Jennifer Meade Named President at Aldevron
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
RBC Capital Sticks to Its Hold Rating for Hologic (HOLX)
Hologic (HOLX) Stock Advances, Joining S&P 500
Hologic (HOLX) Receives a Buy from Mizuho Securities
Hologic (HOLX) Tops Q3 Earnings and Revenue Estimates
Hologic Inc Q3 Earnings Summary
What Wall Street expects from Hologic's earnings
Hologic's Earnings: A Preview
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Company Calendar

Last Earnings
7/31/2023
Today
9/22/2023
Fiscal Year End
9/30/2023
Next Earnings (Estimated)
10/30/2023

Industry, Sector and Symbol

Industry
X-ray apparatus & tubes
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
Employees
6,944
Year Founded
1985

Price Target and Rating

Average Stock Price Forecast
$88.92
High Stock Price Forecast
$105.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+26.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
14 Analysts

Profitability

Net Income
$1.30 billion
Pretax Margin
16.69%

Debt

Sales & Book Value

Annual Sales
$4.86 billion
Cash Flow
$7.69 per share
Book Value
$19.53 per share

Miscellaneous

Free Float
240,876,000
Market Cap
$17.16 billion
Optionable
Optionable
Beta
1.01

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Stephen P. MacMillanMr. Stephen P. MacMillan (Age 59)
    Chairman, CEO & Pres
    Comp: $4.24M
  • Ms. Karleen M. ObertonMs. Karleen M. Oberton (Age 52)
    Chief Financial Officer
    Comp: $1.58M
  • Mr. John M. GriffinMr. John M. Griffin (Age 62)
    Gen. Counsel
    Comp: $1.47M
  • Mr. Jan  VerstrekenMr. Jan Verstreken (Age 55)
    Group Pres of International
    Comp: $1.24M
  • Mr. Paul Malenchini
    Chief Information Officer
  • Ryan M. Simon
    VP of Investor Relations
  • Ms. Elisabeth A. Hellmann (Age 54)
    Sr. VP of Global HR & Corp. Communications
  • Ms. Monica Aguirre Berthelot
    VP & Chief of Staff
  • Mr. Patrick Brady
    Sr. VP of Global Supply Chain, Quality & Regulatory
  • Mr. Erik Anderson (Age 41)
    Division Pres of Breast & Skeletal Health Solutions













HOLX Stock - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 6 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HOLX shares.
View HOLX analyst ratings
or view top-rated stocks.

What is Hologic's stock price forecast for 2023?

14 brokerages have issued 1 year price objectives for Hologic's shares. Their HOLX share price forecasts range from $70.00 to $105.00. On average, they anticipate the company's stock price to reach $88.92 in the next year. This suggests a possible upside of 26.9% from the stock's current price.
View analysts price targets for HOLX
or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2023?

Hologic's stock was trading at $74.81 on January 1st, 2023. Since then, HOLX shares have decreased by 6.3% and is now trading at $70.07.
View the best growth stocks for 2023 here
.

Are investors shorting Hologic?

Hologic saw a increase in short interest in August. As of August 31st, there was short interest totaling 4,660,000 shares, an increase of 6.2% from the August 15th total of 4,390,000 shares. Based on an average daily trading volume, of 1,760,000 shares, the days-to-cover ratio is currently 2.6 days. Currently, 1.9% of the shares of the stock are sold short.
View Hologic's Short Interest
.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our HOLX earnings forecast
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its earnings results on Monday, July, 31st. The medical equipment provider reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.04. The medical equipment provider earned $984.40 million during the quarter, compared to analyst estimates of $960.22 million. Hologic had a trailing twelve-month return on equity of 19.02% and a net margin of 11.99%. The company's quarterly revenue was down 1.8% on a year-over-year basis. During the same quarter last year, the business posted $0.95 EPS.
Read the conference call transcript
.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its FY23 earnings guidance on Monday, July, 31st. The company provided earnings per share guidance of $3.87-$3.94 for the period, compared to the consensus EPS estimate of $3.91. The company issued revenue guidance of $3.995-$4.035 billion, compared to the consensus revenue estimate of $4.01 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.74%), Bank Julius Baer & Co. Ltd Zurich (8.97%), State Street Corp (4.71%), Geode Capital Management LLC (2.20%), Victory Capital Management Inc. (1.81%) and JPMorgan Chase & Co. (1.37%). Insiders that own company stock include Benjamin Jordan Cohn, Essex D Mitchell, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Scott T Garrett, Sean S Daugherty and Sean S Daugherty.
View institutional ownership trends
.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $70.07.

How much money does Hologic make?

Hologic (NASDAQ:HOLX) has a market capitalization of $17.16 billion and generates $4.86 billion in revenue each year. The medical equipment provider earns $1.30 billion in net income (profit) each year or $1.93 on an earnings per share basis.

How many employees does Hologic have?

The company employs 6,944 workers across the globe.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The official website for the company is www.hologic.com. The medical equipment provider can be reached via phone at (508) 263-2900, via email at michael.watts@hologic.com, or via fax at 781-890-8031.

This page (NASDAQ:HOLX) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -